DMF Medical Inc.

DMF Medical Incorporated is a Canadian-based corporation founded in 2011 with the sole purpose of making anesthesia safer. The company’s lead product – memsorb™ – is a next generation carbon dioxide (CO2) filter for anesthesia circuits, which uses patented membrane separation technology to remove CO2 rather than the traditional chemical reaction. This device provides a game-changing solution to the known dilemma associated with current CO2 absorbers and their production of compounds that are harmful to the patient. memsorb™ boasts further advantages over the current technology standard through its cost savings, simplicity & reliability, and environmental stewardship.